Broadens global development program for verekitug into third indication, strengthening pipeline across severe respiratory diseases including chronic rhinosinusitis with nasal polyps (CRSwNP), severe ...

According to data from the Health Insurance Review and Assessment Service in 2023, there are an estimated 15,000 patients ...

As the BMC roll out the ban on feeding pigeons in designated spots, its success will depend on sustained enforcement and a ...

STOBOCLO ® (denosumab-bmwo) and OSENVELT ® (denosumab-bmwo) are approved by FDA for all indications of PROLIA ® (denosumab) and XGEVA ® (denosumab) respectively [1], [2] STOBOCLO and OSENVELT, among ...